Literature DB >> 18064302

Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.

Nathalie Scamuffa1, Geraldine Siegfried, Yannick Bontemps, Liming Ma, Ajoy Basak, Ghislaine Cherel, Fabien Calvo, Nabil G Seidah, Abdel-Majid Khatib.   

Abstract

The proprotein convertases (PCs) are implicated in the activation of various precursor proteins that play an important role in tumor cell metastasis. Here, we report their involvement in the regulation of the metastatic potential of colorectal tumor cells. PC function in the human and murine colon carcinoma cell lines HT-29 and CT-26, respectively, was inhibited using siRNA targeting the PCs furin, PACE4, PC5, and PC7 or by overexpression of the general PC inhibitor alpha1-antitrypsin Portland (alpha1-PDX). We found that overexpression of alpha1-PDX and knockdown of furin expression inhibited processing of IGF-1 receptor and its subsequent activation by IGF-1 to induce IRS-1 and Akt phosphorylation, all important in colon carcinoma metastasis. These data suggest that the PC furin is a major IGF-1 receptor convertase. Expression of alpha1-PDX reduced the production of TNF-alpha and IL-1alpha by human colon carcinoma cells, and incubation of murine liver endothelial cells with conditioned media derived from these cells failed to induce tumor cell adhesion to activated murine endothelial cells, a critical step in metastatic invasion. Furthermore, colon carcinoma cells in which PC activity was inhibited by overexpression of alpha1-PDX when injected into the portal vein of mice showed a significantly reduced ability to form liver metastases. This suggests that inhibition of PCs is a potentially promising strategy for the prevention of colorectal liver metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18064302      PMCID: PMC2117762          DOI: 10.1172/JCI32040

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Processing of wild-type and mutant proinsulin-like growth factor-IA by subtilisin-related proprotein convertases.

Authors:  S J Duguay; W M Milewski; B D Young; K Nakayama; D F Steiner
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

2.  Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis.

Authors:  P Brodt; L Fallavollita; R S Bresalier; S Meterissian; C R Norton; B A Wolitzky
Journal:  Int J Cancer       Date:  1997-05-16       Impact factor: 7.396

3.  Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.

Authors:  F Rininsland; T R Johnson; C L Chernicky; E Schulze; P Burfeind; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

4.  Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.

Authors:  Yiping Wu; Shoshana Yakar; Ling Zhao; Lothar Hennighausen; Derek LeRoith
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

5.  Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro.

Authors:  N Simiantonaki; C Jayasinghe; C J Kirkpatrick
Journal:  Exp Mol Pathol       Date:  2002-08       Impact factor: 3.362

Review 6.  Management of hepatic metastases.

Authors:  M A Choti; G B Bulkley
Journal:  Liver Transpl Surg       Date:  1999-01

7.  Altered processing of the neurotensin/neuromedin N precursor in PC2 knock down mice: a biochemical and immunohistochemical study.

Authors:  Pierre Villeneuve; Sylvain Feliciangeli; Gilles Croissandeau; Nabil G Seidah; Majambu Mbikay; Patrick Kitabgi; Alain Beaudet
Journal:  J Neurochem       Date:  2002-08       Impact factor: 5.372

8.  Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis.

Authors:  Abdel-Majid Khatib; Lucia Fallavollita; Edward V Wancewicz; Brett P Monia; Pnina Brodt
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

9.  Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis.

Authors:  S J Duguay; Y Jin; J Stein; A N Duguay; P Gardner; D F Steiner
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

10.  Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression.

Authors:  Wenyi Che; Nicole Lerner-Marmarosh; Qunhua Huang; Masaki Osawa; Shinsuke Ohta; Masanori Yoshizumi; Michael Glassman; Jiing-Dwan Lee; Chen Yan; Bradford C Berk; Jun-Ichi Abe
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

View more
  49 in total

1.  Molecular Validation of PACE4 as a Target in Prostate Cancer.

Authors:  François D'Anjou; Sophie Routhier; Jean-Pierre Perreault; Alain Latil; David Bonnel; Isabelle Fournier; Michel Salzet; Robert Day
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

Review 2.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

3.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

4.  Opposite roles of furin and PC5A in N-cadherin processing.

Authors:  Deborah Maret; Mohamad Seyed Sadr; Emad Seyed Sadr; David R Colman; Rolando F Del Maestro; Nabil G Seidah
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

5.  Regulation of HIF-1 alpha by the proprotein convertases furin and PC7 in human squamous carcinoma cells.

Authors:  Jian Fu; Jirong Zhang; Yulan Gong; Courtney Lyons Testa; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2014-01-16       Impact factor: 4.784

6.  A femtomol range FRET biosensor reports exceedingly low levels of cell surface furin: implications for the processing of anthrax protective antigen.

Authors:  Katarzyna Gawlik; Albert G Remacle; Sergey A Shiryaev; Vladislav S Golubkov; Mingxing Ouyang; Yingxiao Wang; Alex Y Strongin
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

7.  Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.

Authors:  Katarina Hajdin; Valentina D'Alessandro; Felix K Niggli; Beat W Schäfer; Michele Bernasconi
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

8.  Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.

Authors:  Claude Lalou; Nathalie Scamuffa; Samia Mourah; Francois Plassa; Marie-Pierre Podgorniak; Nadem Soufir; Nicolas Dumaz; Fabien Calvo; Nicole Basset-Seguin; Abdel-Majid Khatib
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

9.  Zebrafish ProVEGF-C expression, proteolytic processing and inhibitory effect of unprocessed ProVEGF-C during fin regeneration.

Authors:  Abdel-Majid Khatib; Rachid Lahlil; Nathalie Scamuffa; Marie-Andrée Akimenko; Sylvain Ernest; Abdderahim Lomri; Claude Lalou; Nabil G Seidah; Bruno O Villoutreix; Fabien Calvo; Geraldine Siegfried
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

10.  The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model.

Authors:  Xiaowei Sun; Rachid Essalmani; Nabil G Seidah; Annik Prat
Journal:  Mol Cancer       Date:  2009-09-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.